REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09995 REMEGEN

Noon Closed 05-22 12:05:00

85.600

-0.650

-0.75%

High87.700	Low83.650	Vol1.57M
Open87.700	D1 Closing86.250	Amplitude4.70%
Mkt Cap48.24B	Tradable Cap17.85B	Total Shares563.61M
T/O133.81M	T/O Rate0.75%	Tradable Shares208.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"REMEGEN","latestPrice":85.6,"timestamp":1779422700010,"preClose":86.25,"halted":0,"volume":1574637,"delay":0,"changeRate":-0.007536231884058037,"floatShares":208581239,"shares":563608243,"eps":1.4863419240081805,"marketStatus":"Noon Closed","change":-0.65,"latestTime":"05-22 12:05:00","open":87.7,"high":87.7,"low":83.65,"amount":133807863,"amplitude":0.046957,"askPrice":85.65,"askSize":1500,"bidPrice":85.4,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":2.68970047652779,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779426000000},"marketStatusCode":3,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":86.25,"openAndCloseTimeList":[[1779413400000,1779422400000],[1779426000000,1779436800000]],"volumeRatio":0.963533,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"Remegen Co.,Ltd.","latestPrice":116.08,"timestamp":1779420599000,"preClose":121.99,"halted":0,"volume":8869400,"delay":0,"premium":"-36.00"}},"requestUrl":"/m/hq/s/09995/wiki","defaultTab":"wiki","newsList":[{"id":"2637136289","title":"Junshi Biosciences Gets Nod for New Indication for Toripalimab; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637136289","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637136289?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:07","pubTimestamp":1779419249,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences  received a drug registration certificate from China's National Medical Products Administration for a new indication for toripalimab, according to a Hong Kong bourse filing on Thursday.The pharmaceutical company's Shanghai shares dropped by less than 4%, while Hong Kong shares fell by less than 2% during Friday's morning trade.The drug, which trades as Tuoyi, will be allowed for the treatment for HER2-expressing locally advanced or metastatic urothelial carcinoma in combination with disitamab vedotin, an antibody drug conjugate developed by RemeGen .","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","LU1064130708.USD","688180","BK1583","LU1064131003.USD","688331","BK0239","LU1969619763.USD","LU2148510915.USD","LU2488822045.USD","BK1515","BK1161","09995","LU2328871848.SGD","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115613674","title":"Movement Alert｜RemeGen Rises 3.55% in Regular Trading, Biotech Sector Rally and Strong Q1 Earnings Drive Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1115613674","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115613674?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:52","pubTimestamp":1779328351,"startTime":"0","endTime":"0","summary":"On May 21, RemeGen rose 3.55% in regular trading, trading at HK$88.6/share, with trading volume of approximately HK$112 million.On the news front, the broader biotechnology sector staged a collective...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131448277","title":"RemeGen Allocates Additional RMB50.00 Million to HTSC Wealth Management Products, Raising Total Deployment to RMB538.00 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1131448277","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131448277?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:03","pubTimestamp":1779271399,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. (RemeGen) disclosed that on 20 May 2026 it signed two new agreements—HTSC Wealth Management Product Agreement No. 7 and No. 8—with Huatai Securities Co., Ltd. (HTSC), committing a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161325679","title":"RemeGen Plans Board Transition, 20% Share Issuance Mandate, and Redirects IPO Proceeds Amid 2025 Profit Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=1161325679","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161325679?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:02","pubTimestamp":1779271377,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. has called its 2025 annual general meeting (AGM) for 16 June 2026 in Yantai to vote on 13 resolutions spanning financial results, capital management, board renewal and project...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127524631","title":"REMEGEN issues supplemental disclosure after delayed reporting of seven wealth-management product purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=1127524631","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127524631?lang=en_us&edition=fundamental","pubTime":"2026-05-19 21:03","pubTimestamp":1779195835,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. (REMEGEN) released a supplemental announcement clarifying disclosure lapses related to seven wealth-management products bought from SPD Bank Wealth Management between 28 April and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137444504","title":"REMEGEN Allocates Additional 35 Million Yuan to Huatai Securities Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1137444504","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137444504?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:30","pubTimestamp":1779190216,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) has announced that on May 19, 2026, the company entered into further agreements with Huatai Securities. Specifically, the company signed (1) the Huatai Securities Wealth Management...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0531971595.HKD","LU1979443071.USD","BK0183","BK1574","BK0239","601688","LU2488822045.USD","LU0871576103.HKD","688331","BK0188","BK1161","LU0164865239.USD","BK1583","09995","LU1934453819.USD","LU1064131003.USD","LU1580142542.USD","BK0028","BK0276","LU2148510915.USD","LU1064130708.USD","LU1781817850.SGD","LU2328871848.SGD","LU1808992512.USD","LU1969619763.USD","LU0039217434.USD","BK0012","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635567775","title":"RemeGen Invests in Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2635567775","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635567775?lang=en_us&edition=fundamental","pubTime":"2026-05-15 10:10","pubTimestamp":1778811013,"startTime":"0","endTime":"0","summary":"RemeGen  said it invested in various wealth management products offered by Huatai Securities, according to a Friday filing with the Hong Kong bourse.The biopharmaceutical company invested 60 million yuan in a fixed-income product that invests in debt assets, 75 million yuan in another fixed-income product that covers liquid financial instrument, and a further 102 million yuan in a fixed-income product tied to financial products and cash-type assets.The company also invested 216 million yuan in a ten-year product that will be invested in financial products and cash-type assets.The firm said the products will help \"revitalize idle funds.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LU1969619763.USD","BK0239","LU1064130708.USD","BK1583","LU2148510915.USD","688331","LU1064131003.USD","LU2488822045.USD","BK1574","09995","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116342410","title":"REMEGEN Allocates Idle Capital to Huatai Securities Financial Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1116342410","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116342410?lang=en_us&edition=fundamental","pubTime":"2026-05-15 07:08","pubTimestamp":1778800132,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) has announced that on May 14, 2026, the company entered into agreements with Huatai Securities to purchase financial products using its idle proprietary funds. The agreements include:...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU1064130708.USD","BK0239","BK1161","09995","BK1583","LU2328871848.SGD","LU1969619763.USD","LU2488822045.USD","LU1064131003.USD","LU2148510915.USD","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149329756","title":"RemeGen Allocates RMB 453.00 Million of Idle Cash to Low-to-Medium-Risk Wealth Management Products at Huatai Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1149329756","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149329756?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:22","pubTimestamp":1778797365,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. on 14 May 2026 signed four agreements with Huatai Securities Co., Ltd. (HTSC) to deploy RMB 453.00 million of temporary idle funds into low- to-medium-risk wealth management...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178809157","title":"RemeGen Allocates US$70.00 Million of Idle Funds to OCBC “Zeng Li” Structured Deposit","url":"https://stock-news.laohu8.com/highlight/detail?id=1178809157","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178809157?lang=en_us&edition=fundamental","pubTime":"2026-05-14 16:45","pubTimestamp":1778748334,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. (RemeGen) has entered into a wealth-management agreement with Oversea-Chinese Banking Corporation Limited (OCBC) to place US$70.00 million of idle self-owned funds in a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174011467","title":"RemeGen Invests $70 Million in Financial Product from OCBC","url":"https://stock-news.laohu8.com/highlight/detail?id=1174011467","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174011467?lang=en_us&edition=fundamental","pubTime":"2026-05-14 16:44","pubTimestamp":1778748260,"startTime":"0","endTime":"0","summary":"RemeGen (09995) announced that on May 14, 2026, the company entered into a financial product agreement with OCBC. Under this agreement, RemeGen agreed to use $70 million of its idle own funds to purchase a financial product from OCBC.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","LU1064130708.USD","LU2148510915.USD","LU2328871848.SGD","LU2488822045.USD","LU1969619763.USD","LU1064131003.USD","688331","09995","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189824917","title":"RemeGen Announces Acquisition of 1.43 Billion Yuan in Bank Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1189824917","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189824917?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:05","pubTimestamp":1778670324,"startTime":"0","endTime":"0","summary":"RemeGen (09995) announced that on April 28, 2026, the company entered into SPDB Wealth Management Product Agreement No. 1 and SPDB Wealth Management Product Agreement No. 2 with SPD Bank Yantai...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2328871848.SGD","BK1574","688331","LU1064130708.USD","LU2148510915.USD","161121","BK1583","LU1969619763.USD","09995","LU2488822045.USD","BK1161","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166588783","title":"HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166588783","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166588783?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:30","pubTimestamp":1778477425,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","02268","03347","09966","06978","03759","09606","02137","01672","09688","02269","02359","06606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184350379","title":"Stock Track | REMEGEN Plummets 5.12% Intraday on Lock-up Expiry Fears, Weak Earnings, and Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1184350379","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184350379?lang=en_us&edition=fundamental","pubTime":"2026-05-11 09:59","pubTimestamp":1778464757,"startTime":"0","endTime":"0","summary":"REMEGEN's stock price plummeted 5.12% during intraday trading on Monday.The sharp decline is attributed to market concerns over a significant lock-up expiry event scheduled for June 30, which will...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120099224","title":"Stock Track | REMEGEN Plummets 6.51% Intraday on Sharp Q1 Profit Decline and Biotech Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1120099224","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120099224?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:49","pubTimestamp":1777859379,"startTime":"0","endTime":"0","summary":"REMEGEN's stock plummeted 6.51% during intraday trading on Monday, reflecting significant selling pressure.The sharp decline follows the company's recently disclosed first-quarter results, which...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631428455","title":"RemeGen Q1 Profit Of ¥328m Revives Bullish Narratives On Biotech Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2631428455","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631428455?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:18","pubTimestamp":1777468732,"startTime":"0","endTime":"0","summary":"RemeGen (SEHK:9995) opened 2026 with Q1 revenue of C¥656.2 million and basic EPS of C¥0.58, following a trailing twelve month stretch that produced total revenue of C¥3.4 billion and basic EPS of C¥2.33. The company has seen quarterly revenue move from C¥508.0 million in Q4 2024 to C¥526.0 million in Q1 2025, then to C¥656.2 million in Q1 2026. EPS shifted from a loss of C¥0.74 in Q4 2024 to a loss of C¥0.46 in Q1 2025 and then to a profit of C¥0.58 in the latest quarter, setting up a results...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-q1-profit-of-328m-revives-bullish-narratives-on-biot","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-q1-profit-of-328m-revives-bullish-narratives-on-biot","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09995","BLSG","688331","BK1161","BK1574","BK4581","LU2328871848.SGD","BK4585","BK4588","LU1969619763.USD","BK4112","BK1583","BLSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631552685","title":"RemeGen Swings to Profit in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2631552685","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631552685?lang=en_us&edition=fundamental","pubTime":"2026-04-29 11:40","pubTimestamp":1777434032,"startTime":"0","endTime":"0","summary":"RemeGen  booked 328 million yuan in attributable profit for the first quarter of 2026, swinging from a loss of 254.1 million yuan a year earlier, according to a Hong Kong bourse filing Tuesday.The biopharmaceutical company's Hong Kong shares were down 2% in late morning trade Wednesday.Earnings per share were 0.58 yuan, compared with a loss of 0.46 year in the prior year period.Operating revenue jumped 25% year on year to 656.2 million yuan, figures showed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","LU2148510915.USD","LU2328871848.SGD","BK1583","BK1161","LU1064131003.USD","LU1969619763.USD","LU2488822045.USD","BK1574","688331","LU1064130708.USD","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173100614","title":"REMEGEN Turns Profitable in Q1 2026 on 24.8% Sales Growth and Sharply Lower R&D Spend","url":"https://stock-news.laohu8.com/highlight/detail?id=1173100614","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173100614?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:44","pubTimestamp":1777383875,"startTime":"0","endTime":"0","summary":"REMEGEN (RemeGen Co., Ltd.) reported a strong turnaround for the three months ended 31 March 2026, moving from a loss a year earlier to solid profitability, driven by higher product sales, reduced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145425240","title":"RemeGen 2025 ESG Report: Energy Intensity Cut by 49%, R&D Investment Reaches RMB1.22 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1145425240","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145425240?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:06","pubTimestamp":1777367204,"startTime":"0","endTime":"0","summary":"RemeGen released its sixth Environmental, Social and Governance Report covering January–December 2025, detailing substantial progress across climate action, product quality, and human capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132316359","title":"荣昌生物2025年实现业绩显著扭转 净利达7.10亿元 营收同比增长89.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132316359","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132316359?lang=en_us&edition=fundamental","pubTime":"2026-04-28 16:49","pubTimestamp":1777366153,"startTime":"0","endTime":"0","summary":"香港上市公司RemeGen Co.,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"荣昌生物2025年实现业绩显著扭转 净利达7.10亿元 营收同比增长89.5%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0411},{"period":"1month","weight":-0.2539},{"period":"3month","weight":0.0531},{"period":"6month","weight":0.0661},{"period":"1year","weight":0.839},{"period":"ytd","weight":0.1979}],"compareEarnings":[{"period":"1week","weight":-0.038},{"period":"1month","weight":-0.0416},{"period":"3month","weight":-0.0389},{"period":"6month","weight":0.0066},{"period":"1year","weight":0.0654},{"period":"ytd","weight":-0.0095}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.043269},{"month":6,"riseRate":0.8,"avgChangeRate":0.127757},{"month":7,"riseRate":0.6,"avgChangeRate":-0.032319},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"REMEGEN","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"REMEGEN,09995,REMEGEN股票,REMEGEN股票老虎,REMEGEN股票老虎国际,REMEGEN行情,REMEGEN股票行情,REMEGEN股价,REMEGEN股市,REMEGEN股票价格,REMEGEN股票交易,REMEGEN股票购买,REMEGEN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}